- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹43 Cr4,315th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −2.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 4 Jun 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,530
Prism Medico and Pharmacy share news and announcements
816 announcements, routine notices left out, newest first. Page 2 of 17.
Nov 2025
6 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Oct 2025
27 Oct · Undertaking Of Functional Website.
17 Oct · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
1 Oct · Compliance-57 (5) : intimation after the end of quarter
1 Oct · Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Sep 2025
5 Sep · Annual Report For The Financial Year 2024-2025.
1 Sep · Board meeting
Meeting on 5 Sep 2025
Aug 2025
7 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results7 Aug · Announcement under Regulation 30 (LODR)-Meeting Updates
Jul 2025
15 Jul · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
1 Jul · Compliance-57 (5) : intimation after the end of quarter
Jun 2025
30 Jun · Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
May 2025
28 May · Details Of Related Party Transactions (RPT'S) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
20 May · Board meeting
Meeting on 28 May 2025: quarterly results and audited results
Apr 2025
25 Apr · Submission Of Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2025.
9 Apr · Submission Of Compliance Certificate As Per Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 During The Financial Year Ended 31St March, 2025.
7 Apr · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
1 Apr · Compliance-57 (5) : intimation after the end of quarter
Mar 2025
31 Mar · Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Feb 2025
7 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results
Jan 2025
18 Jan · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
4 Jan · Intimation Under Regulation 57(5) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.
4 Jan · Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.